XML 19 R10.htm IDEA: XBRL DOCUMENT v3.22.2

Segment information	6 Months Ended
	Jun. 30, 2022
Text Block [Abstract]
Segment information	4. Segment information The Group manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Group’s focus is on the research and development of T cell redirecting immunotherapies for the treatment of cancer. The Chief Executive Officer is the chief operating decision maker who regularly reviews the consolidated operating results and makes decisions about the allocation of the Group’s resources.

X

- Definition

The entire disclosure for operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2021-01-01
-Section Disclosure
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Text block.

+ References

No definition available.

+ Details

Name:	imtx_TextBlockAbstract
Namespace Prefix:	imtx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration